No, Atlanta is not experiencing an outbreak of HIV, although the rates of new diagnosis are considered high in some ...

Despite recent ASCO and FDA guidance recommending the inclusion of people living with HIV in pivotal cancer trials, nearly 75 ...

Canceled grants and slashed budgets are disproportionately affecting junior health researchers, dealing a major blow to the ...

Thirty-five years ago, the multimillion dollar fundraiser Seventh on Sale propelled the fashion industry into a new era of ...

Watch the creamy layers of this iced latte swirl together as a glass stir stick gently stirs the magic 🌀. Captured in natural light with plant shadows in the background, this relaxing coffee moment ...

The US Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as preexposure prophylaxis (PrEP) to reduce the risk for sexually acquired HIV.

Anal cancer screening among men who have sex with men with HIV aged 35 years and older appeared cost-effective and could decrease anal cancer incidence and mortality, according to research published ...

Not everyone knows that gay pageants are not only fodder for internet virality or the butt of a joke, they can also be an ...

In a critical victory for patients on June 27th, the Supreme Court has determined that health insurance plans under the ...

Tessie San Martin talks about leading the Durham global research firm after losing half its revenue and why sustainable ...

A miyah Buan was sure she’d be starting her Ph.D. this fall after applying to eight graduate programs in biochemistry.

Gilead has partnered with six generic manufacturers to expand access to HIV Drug lenacapavir in high-incidence, resource-limited countries following promising clinical trial results.